Intarcia Therapeutics, Inc.

General Information
Company Name
Intarcia Therapeutics, Inc.
Founded Year
1997
Location (Offices)
Boston, United States +3
Founders / Decision Makers
Number of Employees
76
Industries
Biotechnology, Health Care, Health and Wellness +1
Funding Stage
Series Unknown
Social Media

Intarcia Therapeutics, Inc. - Company Profile

Intarcia Therapeutics, Inc. is a rapidly emerging biotech company driven by a "No Analog" mindset, dedicated to redesigning the treatment, prevention, and experience of chronic diseases. Founded in 1997, the company operates in the Biotechnology and Health Care industries, with its headquarters in the United States.

The company's commitment to seeking better outcomes and creating meaningful impact across business, health, and society is evident in its relentless pursuit of innovative solutions. Its cross-disciplinary teams, comprising forward-thinking scientists and entrepreneurs, operate in a fast-paced environment, continually pushing boundaries and unleashing fresh thinking.

Intarcia's latest investment, a Venture Round investment at 29 August 2019, was secured from GGV Capital. This signals investor confidence in the company's mission and potential to redefine the future of medicine.

Overall, Intarcia Therapeutics, Inc. presents an intriguing opportunity for venture capital firms seeking to invest in a company at the forefront of pioneering solutions in the biotech and healthcare sectors. With a strong focus on innovation and impact, the company is poised to continue making strides in improving the lives of individuals living with chronic diseases.

Taxonomy: biotech, medical innovation, chronic disease treatment, biopharmaceuticals, health impact, innovative therapies, cross-disciplinary collaboration, medical research, future of medicine

Funding Rounds & Investors of Intarcia Therapeutics, Inc. (15)

View All
Funding Stage Amount No. Investors Investors Date
Debt Financing $73.13M - 26 Feb 2019
Secondary Market Unknown 1 13 May 2017
Debt Financing $75.00M 2 Silicon Valley Bank 07 May 2016
Venture Round $225.00M - 27 Apr 2015
Venture Round $200.00M 6 Farallon Capital Management, Alger 01 Apr 2014

View All 15 Funding Rounds

Latest News of Intarcia Therapeutics, Inc.

View All

No recent news or press coverage available for Intarcia Therapeutics, Inc..

Similar Companies to Intarcia Therapeutics, Inc.

View All
Neuralace Medical - Similar company to Intarcia Therapeutics, Inc.
Neuralace Medical Beyond Chronic Pain
Healthcare Business International - Similar company to Intarcia Therapeutics, Inc.
Healthcare Business International Creating new ways of thinking about the business and investment of healthcare globally
Tesu Health - Similar company to Intarcia Therapeutics, Inc.
Tesu Health Evidence-based digital therapeutics platform for personalised management of chronic diseases.
MedVadis Research - Similar company to Intarcia Therapeutics, Inc.
MedVadis Research Advancing Health in the Greater Boston Area.
Think Self-Management - Similar company to Intarcia Therapeutics, Inc.
Think Self-Management Providing clinicians with evidence-based chronic disease self-management tools and resources to empower their clients.